Prostatepedia

Conversations With Prostate Cancer Experts


Leave a comment

Vitamin D, Omega-3 Fatty Acids, Curcumin + Prostate Cancer

Dr. David Levy is a Clinical Associate Professor in the Department of Urology at the Cleveland Clinic.

Dr. Levy spoke to Prostatepedia about his clinical trial looking at the impact of vitamin D, curcumin, and Omega-3 fatty acids on prostate cancer.

Not a member? Join us.

Can you explain the thinking behind your clinical trial on vitamin D, Omega-3 fatty acids and curcumin in prostate cancer?

Dr. David Levy: Well first let me say there are a number of people involved in this program without whom it would not be where it is today.

I was extremely fortunate. When I finished my residency in Cleveland, I went to MD Anderson Cancer Center in Houston, Texas to do a cancer fellowship.

At that time, we didn’t really understand why cancer occurs and how to treat it. The attitude was: “Cut it out. Radiate it. Give chemo.”

We’re now twenty years down the road and while medical knowledge has advanced tremendously, what are we still doing? Cut it out. Give radiation. Give chemo. People with cancer keep coming and coming. It’s like a conveyor belt. They don’t stop.

About five years ago, I bought an abandoned farm here in Northeast Ohio. The goal was to make it an organic certified produce farm, which I did over three years. In learning about the process to make our farm certified organic, I had to review all the pesticides and chemicals that had been put into the soil and what we had to avoid for over three years to gain the certification. With all these pesticides and chemicals come known side effects.

There is a journal called the Journal of Organic Sciences, which ran a 25-page article on the use of a very common weed killer. Going back to the 1970s, there is a direct correlation of the increased use of this weed killer in commercial agriculture with an increase in liver cancer, colon cancer, kidney cancer, kidney failure, lymphoma, leukemia, thyroid, and prostate cancers. Every cancer went up. They all paralleled the increased use of this common weed killer.

When I read that article, I started to think that there has to be some correlation between environmental exposure and cancers. I started to ask: If you change the environment in which the cells live, do you change their behavior? That has been studied a few times and the results published. Studies have shown the influence of vitamin D on prostate cancer behavior, the impact of Omega-3 and Omega-6 fatty acid ratios on prostate cancer behavior, and the impact of turmeric curcumin on biochemical pathways in the cells. I was thinking about all of that as I came to design the trial.

If you look at populations across the world, prostate cancer rates vary quite dramatically. India, China, and Japan have some of the lowest rates of anywhere in the world. The rate in India is 25 times less than that in the United States, England, France, Germany, Norway, Sweden, or Finland. Why is it that? Men in India all have testicles and testosterone and prostates, but they don’t have prostate cancer. The same goes for Japan and China.

There are pretty interesting differences in terms of the eating habits of these populations and the disease processes that are common in the societies.

It turns out, as far as we can tell, that meat and dairy feed prostate cancer. What do we see in this country on NFL Sunday? What do they serve? They serve hot dogs, French fries, chicken fingers, chicken nuggets, chicken wings, and hamburgers. All of these foods are very high in Omega-6 fats. No one goes to the ballpark to get a bag of broccoli. That doesn’t happen. No one goes there to eat apples.

When we look at our society in terms of the food choices, the foods that are heavily advertised are fast foods, pizzas, and sodas. High sugar loads, high glycemic index foods, and animal fats are all very well correlated with prostate, breast, pancreatic, and colon cancers.

I looked a little further into vitamin D and asked, “Is there a correlation with vitamin D and prostate cell behavior?”

It seems there is. One published study looked at 71,900 men—which is a pretty substantial population—for six and a half years. They found that the lower the vitamin D levels in the blood, the higher the patients’ PSAs, the higher the likelihood of a positive prostate biopsy, and the more aggressive their cancers.

Another vitamin D study published by the SEER committee, which is a national organization that correlates hospital reported statistics throughout the country, looked at 20,000 men. Again, they found low vitamin D, higher PSA, and higher odds of a positive prostate biopsy with significant disease.

Other studies correlate vitamin D levels with prostate cell behavior. It turns out that vitamin D binds on the prostate cell to the androgen receptor. That is where testosterone binds, and testosterone is the main food for prostate cells. Vitamin D binds to this receptor as well. As best we can tell, with low vitamin D levels, the prostate cell machinery churns along like a steel furnace. When the vitamin D levels go up, something happens to the cells’ metabolic rates

Across the country, almost all of the residents of the states north of South Carolina border and from East to West

Coasts are low in vitamin D. I haven’t tested anybody here in Cleveland in almost three years with a normal vitamin D level.

What about turmeric curcumin?

Dr. Levy: Tumeric is used in curry and it contains curcumin. Curcumin is a really good anti-inflammatory. It’s a naturally occurring COX-2 inhibitor. (Celebrex was a COX-2 inhibitor.) It turns out that curcumin has a far greater impact on the biochemistry of cells than just an anti-inflammatory. Curcumin impacts what is called the Hypoxia-inducible factor 1-alpha. This is a factor made in the cells that is involved in their ability to recruit new blood vessels to get more oxygen and more nutrients. Curcumin disrupts that cycle.

Curcumin disrupts the mesenchymalepithelial cell transformation. The mesenchymal-epithelial cell transformation is a process that allows cells to gain the ability to climb outside the prostate and spread to the lymph nodes and bones. Curcumin also impacts the diclofenac acid pathway, which is part of the cell’s Omega-6 metabolic pathway.

There are new publications that show curcumin increases cellular sensitivity to radiation treatment. There are some studies that show it increases the cell’s susceptibility to chemotherapy.

There are over 300 publications in the National Library of Medicine on curcumin and prostate cancer right now. When I started this work about 3. years ago, there were 13 publications on curcumin and prostate cancer. There were so few publications I couldn’t even include them in my suggested regimen to patients. Now, there’s no way we can ignore it.

In my opinion, to not include curcumin would be a disservice to patients because it has such a tremendous impact on cellular behavior without being toxic in any way to the kidneys, the liver, the intestinal system, or the cardiovascular system.

There are very few reported side effects of dosing curcumin. Patients have taken as much a 6 grams per day in capsule form in a study protocol to impact their prostate cancer. We give 2,000 milligrams per day, and in 27 months have not seen any side effects that would curtail our continued use of the supplement.

Are you giving men vitamin D, omega-3 fatty acids, and curcumin all at the same time and then measuring the outcome, or are you separating them out into different groups?

Dr. Levy: No. We’re giving them all together.

After you give patients a combination of the three supplements what kinds of measurements are you doing?

Dr. Levy: We measure the fatty acid ratios in the body. We measure the three individual components of the fish oil:

EPA, DHA, and DPA. We measure the Omega-3/Omega-6 ratios in the blood. We measure linoleic acid levels in the blood. We measure vitamin D levels, and then titrate their doses to get vitamin D levels up to our target range.

There is nothing you can do to measure curcumin except give the dose of the appropriate manufacturer’s preparation.

We spent a lot of time figuring out what was going to get to the cells most efficiently.

And of course, we change the diet.

But the end point of our study is genetics. We do a tissue biopsy at the time of diagnosis. Then the men go on nutrition modification and supplements for a minimum of nine months. After nine months, we repeat the prostate biopsy and do a side-by-side genetic comparison of the prostate tissue from before the diet and supplements regimen with the tissue from after the diet and supplements regimen. Then we see what kinds of changes we have caused by changing the environment in which the cells live.

What kind of patients are you looking for?

Dr. Levy: For the purposes of this genetic study, we are specifically looking at people with low-risk prostate cancer who are on active surveillance or who are candidates for active surveillance.

Not a member? Join Prostatepedia to read the rest of our December conversations on diet, lifestyle, and prostate cancer.

 


Leave a comment

Diet + Lifestyle During Treatment

Ms. Greta Macaire is a registered dietician at the University of California, San Francisco.

She spoke with Prostatepedia about the types of recommendations she makes for men with prostate cancer during treatment.

Join us to read the rest of our December conversations on diet and lifestyle for prostate cancer.

What do you recommend for men about to start radiation, have surgery, or begin chemotherapy?

Ms. Greta Macaire: I always tell men undergoing radiation, surgery, or chemotherapy that there will be side effects from those treatments. They may need to modify their diet.

For example, patients who get radiation to the prostate bed in the pelvic area (or if lymph nodes are involved) can experience side effects such as gas, bloating, loose stools, and diarrhea. To decrease these side effects, they may have to modify their diet. These are almost always temporary recommendations, though, so it can be really confusing for men.

As a good diet for men with prostate cancer, everyone would recommend a lot of broccoli and vegetables. But men who go into radiation might get gas, bloating, and diarrhea, so they may need to avoid gas-producing vegetables and acidic foods like tomatoes to decrease these side effects. We would also recommend less fiber and more cooked vegetables in that case. But I always let them know these are temporary changes.

Once they recover from radiation, they’ll be able to introduce all these foods back into their diet gradually. It can be a little unnerving for them to think about backing off those foods that they feel are so important. The digestive tract usually heals pretty quickly from something like radiation, so it’s just temporary. Typically, we incorporate those foods back in within a couple of weeks after treatment.

Surgery can also result in gas and bloating because of the pain medications. Constipation and gas can be really uncomfortable because of the surgery. Again, that’s usually temporary.

Any dietary changes before chemotherapy?

Ms. Macaire: The most common side effect I hear about is taste changes: some foods are not appealing or taste like cardboard or metal. Nausea and decreased appetite are other common side effects.

You may have to plan out what you’re going to eat. Eat smaller meals, and eat more often. That way, you’re not getting too much so you’re not going to feel bloated and uncomfortable, but then you’re not going all day without eating, which will make nausea worse. If you experience a metallic taste, we can look at ways to tweak the flavor profile of foods to make them tastier.

Sometimes animal protein brings out the metals in food. There’s more iron and things like that even in chicken or fish. Choose alternative protein sources that don’t have as much of the metallic flavor. Lemon juice can brighten up flavor if everything tastes bland. These small modifications can help with the side effects.

I think it’s comforting for people to hear that these changes are temporary. You’re going to like food again. When you’re done with chemo, things will taste good again. Hold tight.

One of the big side effects of androgen deprivation therapy (ADT) is that men tend to gain weight quickly. What do you recommend for men on hormonal therapy?

Ms. Macaire: We strongly recommend physical activity. The research is pretty consistent on physical activity. Cardiovascular exercise is important, but resistance training is also important. Resistance training maintains lean body mass, which keeps the metabolism higher. The more muscle they can maintain and not lose due to hormone therapy, the more they can keep their body composition on track.

Men on hormone therapy need to be careful about what they eat, especially with foods that can cause weight gain: white foods—which can cause abdominal weight gain—like refined grains and sugary beverages (soda, fruit juice), desserts, and pastries. It’s really important to eat more green leafy vegetables, fill your plate with filling, high-fiber foods. Make at least half your plate non-starchy vegetables, fill a quarter of the plate with lean or plant protein and limit grains or starchy vegetables like potatoes, corn, or peas to no more than the other quarter of the plate.

I wouldn’t recommend a low-carb diet by any means, but eating lots of vegetables and including a lean protein with each meal will help to keep blood sugar levels stable, to prevent spikes and drops.

Join us to read the rest of Ms. Macaire’s comments about her diet and lifestyle recommendations for prostate cancer patients.


Leave a comment

Exercise + Metastatic Prostate Cancer?

Professor Rob Newton is the Associate Dean of Medical and Exercise Sciences and the Co-Director of the Exercise Medicine Research Institute, School of Medical and Health Sciences at Edith Cowan University in Perth, Australia.

Prostatepedia spoke to Dr. Newton about his exercise for men with metastatic prostate cancer.

Not a member? Join us to read our December issue on diet, lifestyle, and prostate cancer.

What exercises do you recommend for men with metastatic prostate cancer?

Dr. Rob Newton: Traditionally, the recommendation for patients with metastatic disease was to rest. The patient should avoid physical activity, and weight/resistance training in particular, due to concerns that bones might fracture at a point of weakness.

We’ve run two studies that challenge this idea. One has been published; the other is ongoing. We’ve been exercising men with metastatic prostate cancer and women with metastatic breast cancer and we’ve seen no adverse events—no increase in pain medication. We’ve seen good physiological responses and improved fitness, strength, and muscle size. It appears that in a well-controlled environment, with appropriately qualified personnel, the risk of a fracture at the site of metastasis is very low.

We use accredited exercise physiologists, but in the United States, men should find a clinical exercise physiologist in a good, monitored facility. Patients respond very well.

It’s counterproductive to recommend to patients with metastatic disease that they rest because they’ll only decline faster and die quicker. Physical inactivity is not an option; they have to exercise. The challenge is to implement this safely and effectively.

Clearly, a home-based program is inadvisable. These patients most likely will have cardiovascular issues, so they’re at risk of having a heart attack or stroke. Their program needs to be monitored by the right personnel using the correct equipment with sound emergency procedures. Our recommendation—and what we have implemented—is a clinic-based program, supervised by exercise physiologists.

In those particular clinical trials, we designed a program so that the exercises avoided the side of the metastasis. For example, if they had a lesion in their left femur, then we wouldn’t exercise that limb to avoid overloading it and causing a fracture.

Some preclinical work in an animal model showed that controlled exercising on the metastatic site compressed tumor progression. When you load bone, bone cells send chemical and electrical signals to other cells that they should respond, generally by laying down more bone to make the bone stronger. Those same electrical and chemical signals also suppress tumor cells.

We have two trials running currently —one in breast cancer and one in prostate cancer—looking at exercise for patients with metastatic spinal lesions. We’re doing controlled isometric contractions to produce compressive load on the side of the lesion. Then we’re using sophisticated MRI techniques to monitor the volume of the metastatic tumors.

Those two studies are ongoing but, again, we’ve had no adverse effects. We have no exacerbation of bone pain. We’re just waiting now for the complete studies to see if, relative to usual care, we’ve observed a slower rate of growth of the bony metastases.

What would you suggest to a man with metastatic disease reading this? Contact his doctor to develop an exercise program?

Dr. Newton: If he has metastatic disease within the skeleton, then he has to avoid any risk of falling. Obviously, contact sports are out, as well as waterskiing, skiing, and snowboarding. It’s critical he exercises. It’s critical he does both aerobic and resistance exercise.

Currently, we recommend he avoid loading the specific site of the metastases, but in the near future, we may see a prescribed exercise program that targets and controls loading. An oncologist or physician would not be able to prescribe an exercise program because they have no background or training in exercise physiology. You have to have the right medical professional give the right exercise prescription.

In Australia, we’re strongly encouraging people to seek the consultation of an accredited exercise physiologist. In the United States, you would look for a clinical exercise physiologist. The American College of Sports Medicine (http://www.acsm.org/) now has specific certifications for exercise oncology, but as this is a relatively new field, there are not many of these health professionals out there at the moment. But the field is growing and specialists can be found.

What if a prostate cancer patient can’t find the right exercise doctor?

Dr. Newton: Visit Movember, which has some support programs in the United States. In Australia, which is as big a country geographically as the United States, we now manage around 2,000 men with prostate cancer entirely via telephone and online.

You mentioned the American Cancer Society’s recommendations for exercise as 75 to 150 minutes a week. Do you think that’s adequate?

Dr. Newton: Absolutely. Seventy-five to 150 minutes per week of moderate to vigorous aerobic exercise and two or more resistance training sessions per week is sufficient to maintain normal health. That means that if you do vigorous exercise, 75 minutes is sufficient. That is for healthy people. If you’ve got cancer, you’re going to have to be more specific about the exercise you do. You’re going to have to do exercise medicine that will give you the best cancer survival.

It’s highly problematic to recommend to patients that they be more physically active. For example, if a patient likes walking and decides to do more walking, that might benefit some aspects of their health. But walking will not benefit a man on ADT who has rapidly developing osteoporosis and sarcopenia (muscle loss). Walking will benefit his cardiorespiratory system, but that probably won’t be what kills him.

Most likely, he’ll become dysfunctional due to low muscle mass and he’ll have an osteoporotic fracture. If it’s in the hip, he probably won’t survive it.

These generic recommendations are helpful generically, but if you have cancer you really need to be assessed by a specialist. That specialist can determine your life-limiting factor and then prescribe medicine tailored to reduce that factor.

Precision exercise medicine?

Dr. Newton: Exactly. We’re working a lot with men with advanced disease, and the American Cancer Society guidelines are difficult for them, particularly if they’ve got cachexia, or muscle wastage. Most likely, 150 minutes per week of moderate intensity exercise is counterproductive. That makes for a greater energy imbalance; they will lose more muscle.

You’ve got to be a little bit careful, particularly with patients who are having a difficult time due to treatment or the stage of their disease. Exercise must be targeted.

That said, any exercise is better than none. The overwhelming clinical evidence and research show that men with prostate cancer—or anyone with any cancer—regardless of the stage of disease, even while undergoing difficult treatments, must be physically active on most, if not, every day of the week. If they adopt a rest strategy, then they will only deteriorate faster. We totally reject the rest strategy; it doesn’t work.

Any amount of physical activity is beneficial and will likely increase survival, but a targeted exercise prescription will be far more effective and safer. We must move to the next stage where highly tailored exercise medicine is standard.

Not a member? Join us to read the rest of Dr. Newton’s comments on exercise + prostate cancer.


Leave a comment

Exercise Programs For Prostate Cancer

Professor Rob Newton is the Associate Dean of Medical and Exercise Sciences and the Co-Director of the Exercise Medicine Research Institute, School of Medical and Health Sciences at Edith Cowan University in Perth, Australia.

Prostatepedia spoke to Dr. Newton about his exercise recommendations for men with prostate cancer.

Not a member? Join us to read our December issue on diet, lifestyle, and prostate cancer.

What specific exercise plans do you recommend for prostate cancer patients?

Dr. Newton: At the moment, we have a very generic recommendation from the American Cancer Society: complete 75 to 150 minutes per week of moderate to vigorous aerobic exercise and two or more resistance training sessions per week. That’s the same recommendation that the American College of Sports Medicine gives for any healthy adult, whether he or she has cancer or not. That recommendation needs to be more tailored to the stage of prostate cancer and the treatments the patient is undergoing.

I’m writing a letter to the Journal of Clinical Oncology in response to a paper by a group in Perth that they published in the last edition. The paper recommends that the way forward with the management of cancer will be home-based exercise programs prescribed by physicians, and most likely, walking programs. This is a tragic step backward in terms of the management of cancer with exercise medicine. It’s ineffective.

Compliance in home-based programs is woeful. It’s the wrong medicine. Depending on the problem the patient is experiencing, walking may be the wrong medicine. It’s like giving antibiotics as contraception. This is not the direction in which oncology should go.

For men on active surveillance, we have two principal targets. First, we try to reduce the risk of other chronic diseases. At this stage, the prostate cancer is not progressing that fast, so chances are the patients are going to die of something else.

If they’re overweight, obese, or their blood glucose is out of control, for example, metabolic syndrome will kill them long before their prostate cancer will. You’ve got to say, “Why are you worried about your prostate cancer? You won’t live long enough to get it.” If a man is overweight, physically inactive, or has a poor diet, then the focus should be on controlling that, not on the prostate cancer.

The other target for patients on active surveillance is to stimulate the mechanisms that might inhibit the tumor from developing further. We’re starting to get a good understanding of this. The key is to maintain or increase the amount of muscle in the patient’s body.

Muscle produces strong antitumor drugs. It’s natural, internal medicine, but it produces a range of substances that have an antitumor effect. We need to increase the size of the muscle and then activate that muscle regularly to get it to dispense these chemicals.

We’re unsure at the moment of what specific types of exercise drive the greatest quantity and which specific endogenous medicine will suppress tumor growth. At this stage, that’s why we recommend a combination of resistance exercise and aerobic exercise. That should help to slow the tumor progression.

Join us to read the remainder of Dr. Newton’s comments.


Leave a comment

Dr. Mark Moyad: Diet, Lifestyle + Prostate Cancer

Moyad Headshot-2Dr. Mark A. Moyad, the Jenkins/Pokempner Director of Complementary and Alternative Medicine in the Department of Urology at the University of Michigan Medical Center, has published over 150 medical journal articles and 12 books, including The Supplement Handbook: A Trusted Expert’s Guide to What Works & What’s Worthless For More Than 100 Conditions.

Dr. Moyad frames this month’s conversations on diet and lifestyle for prostate cancer.

Join us to read the entire issue.

First, I’d like to say that I find it incredibly wonderful that we’re now talking about diet and exercise for prostate cancer. In the old days, it was unusual to even talk about it, but now you stick out if your institution doesn’t cover diet and exercise. What a wonderful and diverse collection of experts in this issue—such a pleasure to read and learn from some of the best in this field now and in the future.

I always say that heart-healthy is prostate-healthy. Heart-healthy is all healthy. Reducing your cardiac risk as close to zero as possible is the smartest thing you can do as a prostate patient. That’s the top of the pyramid when it comes to diet and exercise for prostate cancer. Maintaining a health weight is the first step in becoming heart-healthy.

Every few years, we realize that more and more cancers are associated with obesity. Now we know that obesity is associated with up to at least 13 types of cancer, not to mention the ongoing, ravaging obesity epidemic.

That said, I don’t believe that we have neither the power nor the right to tell people what diet to follow. It doesn’t matter if you want to go vegan, high fat, or low carb: there’s nothing more important than maintaining a healthy weight and having the heart-healthy numbers to support that healthy weight loss.

The new elephant in the room is alcohol. Alcohol often becomes self-medication in elderly people, but it is one of the largest sabotages to a heart-healthy and prostate-healthy lifestyle.

First, the caloric content of alcohol is high: seven calories per gram. Second, the data clearly show a relationship between excessive insulin production and excessive alcohol exposure. This makes it so easy to gain weight when you drink alcohol. Some of the greatest weight loss I’ve seen in the past 12-months has come when a patient eliminates alcohol. There is also a correlation between alcohol and potentially aggressive prostate cancer. So alcohol makes you gain weight, encourages prostate tumor growth, encourages cardiac risk, and encourages risk of other cancers.

Exercise is important, but we have to be careful as we age. We become very delicate machines. That’s why I agree with Dr. Rob Newton that finding an exercise physiologist is a great idea. We have to be smart about exercise: if you don’t preserve yourself, you won’t be able to stay active and get the benefits of exercise for your prostate cancer.

I’ll also add that the biggest benefit to exercise is a mental health benefit. I love the cardio/metabolic effects of exercise in men on hormonal therapy, but I don’t give a damn if exercise ends up being physically beneficial to cancer patients. What excites me is the impact on the quality of life of a man. Patients are completely different on hormonal therapy when they are regular exercisers. Mentally, they’re still in the game. They’re beautiful to be around.

Socialized exercise also gives you a boost. When you work out in your basement, you’re not getting all the benefits of exercise. When you have a trainer, go to a gym, or work out with support group members, you get an added mental health boost. You can become isolated in exercise.

Finally, I’d like to add that we lose credibility if we don’t follow probability with supplements. The results from the VITAL trial, which looks at vitamin D and cancer in about 26,000 people, will be published next year. I’m going to wait for those results before I recommend higher vitamin D intakes to patients.

Not a member? Join us to read the rest of this month’s conversations on diet and lifestyle.